Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial.

Casper K NielsenCaroline C ØhrstrømInas J K HoujiMads M HelstedLiva S L KroghNicklas J JohansenBolette HartmannJens Juul HolstTina VilsbøllFilip K Krag Knop

Published in: Diabetes care (2023)

Compared with placebo, four weeks of self-administered dasiglucagon effectively reduced clinically relevant hypoglycemia in individuals who had undergone Roux-en-Y gastric bypass surgery.

Keyphrases

gastric bypass
roux en y gastric bypass
double blind
weight loss
obese patients
type diabetes
placebo controlled
clinical trial
glycemic control
bariatric surgery
minimally invasive
phase iii
study protocol
coronary artery bypass
randomized controlled trial
skeletal muscle
smoking cessation